Category: Latest News

  • Dow Jones, S&P, Nasdaq, what’s moving the U.S. markets – New trade ruling, China talks, PCE data

    Dow Jones, S&P, Nasdaq, what’s moving the U.S. markets – New trade ruling, China talks, PCE data

    U.S. stock futures edged down slightly on Friday amid renewed uncertainty around trade tariffs and stalled negotiations with China. Investors are also closely watching the upcoming release of the Federal Reserve’s preferred inflation gauge, while OPEC+ prepares to decide on oil production levels this weekend. Trade Tariffs Back in Play In a surprising twist, the…

  • Dow Jones, S&P, Nasdaq: Stocks Close Higher After Mixed Rulings on Trump’s Tariffs

    Dow Jones, S&P, Nasdaq: Stocks Close Higher After Mixed Rulings on Trump’s Tariffs

    Stocks closed higher on Thursday following mixed court decisions on Trump’s tariffs. An initial ruling blocked tariffs on China and other trade partners, while an appeals court reinstated them temporarily, leaving uncertainty. The Dow, S&P 500, and Nasdaq all rose in response to the fluctuating tariff landscape and recent trade agreements. Stocks edged higher in…

  • U.S. Stocks Close Moderately Higher Following Choppy Trading Day

    U.S. Stocks Close Moderately Higher Following Choppy Trading Day

    After failing to sustain a strong move to the upside early in the session, stocks fluctuated over the course of the trading day on Thursday. The major averages bounced back and forth across the unchanged line before eventually closing moderately higher. The Dow rose 117.03 points or 0.3 percent to 42,215.73, the Nasdaq climbed 74.93…

  • Boeing Shares Rise on Plans to Accelerate 737 MAX Production

    Boeing Shares Rise on Plans to Accelerate 737 MAX Production

    Boeing (NYSE:BA) saw its stock climb 4% following CEO Kelly Ortberg’s announcement of an ambitious plan to scale up production of the company’s popular 737 MAX aircraft. The move signals renewed confidence in Boeing’s recovery efforts and manufacturing capabilities. Speaking at the Bernstein investor conference on Thursday, Ortberg outlined the strategy to increase monthly production…

  • Northrop Grumman Commits $50 Million to Firefly Aerospace to Propel Rocket Development

    Northrop Grumman Commits $50 Million to Firefly Aerospace to Propel Rocket Development

    Northrop Grumman Corp (NYSE:NOC), a leading name in aerospace and defense, has poured $50 million into Firefly Aerospace Inc., a Texas-based startup focused on rocket innovation. The funding, highlighted in a Bloomberg report, will accelerate work on the Eclipse rocket, a joint venture between the two firms that began in 2022. The Eclipse launch vehicle…

  • Servotronics Shares Jump Nearly 25% on Upgraded Buyout Offer from TransDigm

    Servotronics Shares Jump Nearly 25% on Upgraded Buyout Offer from TransDigm

    Servotronics Inc. (NYSE:SVT) saw its stock price rocket by 24.5% after announcing an updated merger agreement with aerospace conglomerate TransDigm Inc., which includes a raised all-cash offer of $47.00 per share for all outstanding shares. The revised acquisition terms came in response to an unsolicited bid Servotronics received from a third party. However, after assessing…

  • Eos Energy Shares Slide 17% After Announcing Dual Capital Raises

    Eos Energy Shares Slide 17% After Announcing Dual Capital Raises

    Shares of Eos Energy Enterprises, Inc. (NASDAQ:EOSE) dropped 17% following the company’s announcement of plans to raise substantial capital through two separate offerings—a $175 million convertible senior notes issuance and a proposed $75 million common stock offering. The energy storage firm explained that the funds raised would support a range of strategic initiatives, including the…

  • ORIC Pharmaceuticals Shares Rally 20% on Encouraging Cancer Drug Trial and Funding Update

    ORIC Pharmaceuticals Shares Rally 20% on Encouraging Cancer Drug Trial and Funding Update

    Shares of ORIC Pharmaceuticals Inc. (NASDAQ:ORIC) jumped 20% following the release of early data from its ongoing Phase 1b clinical study evaluating ORIC-944 in combination with androgen receptor (AR) inhibitors for the treatment of metastatic castration-resistant prostate cancer (mCRPC). The interim results point to promising clinical efficacy and a manageable safety profile, potentially positioning ORIC-944…

  • Eton Pharmaceuticals Gains on FDA Green Light for Pediatric Drug KHINDIVI

    Eton Pharmaceuticals Gains on FDA Green Light for Pediatric Drug KHINDIVI

    Shares of Eton Pharmaceuticals Inc (NASDAQ:ETON) saw a 3.3% boost in premarket trading after the company announced U.S. Food and Drug Administration (FDA) approval of KHINDIVI™ (hydrocortisone) Oral Solution. The new treatment, developed for pediatric patients with adrenocortical insufficiency, represents a key achievement for Eton, which focuses on therapies for rare conditions. KHINDIVI stands out…

  • iPhone 16 Tops Global Smartphone Sales in Early 2025, Surpassing Rivals

    iPhone 16 Tops Global Smartphone Sales in Early 2025, Surpassing Rivals

    A fresh report from Counterpoint Research highlights the most popular smartphones worldwide for the first quarter of 2025, with Apple (NASDAQ:AAPL) and Samsung (USOTC:SSNHZ) once again dominating the rankings. Apple’s latest flagship, the iPhone 16, claimed the top spot for the first time in a Q1 period since 2023. This comeback is credited to the…